Remarks: Methotrexate for the anti-folate class agents, mainly through the inhibition of dihydrofolate reductase obstacles to achieve the synthesis of tumor cells, and inhibit tumor cell growth and reproduction.
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer.